Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin’s lymphoma to apoptosis
-
- Alas
- Creator
Journal
-
- Clin. Cancer Res.
-
Clin. Cancer Res. 7 709-, 2001